Name: The division's H1 performance & expected growth trajectory for the rest of the year
Uploaded: 2022-02-28T11:59:18.179431+00:00
Duration: 1291 s
Channel: Vox Markets
Description: The division's H1 performance & expected growth trajectory for the rest of the year

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/421/003421/video_H28KHpW.mp4#t=375

Vox Markets

The division's H1 performance & expected growth trajectory for the rest of the year

How the ImmunoINSIGHTS platform is typically used

Strategy of developing preferred supplier agreements with the world’s top BioPharmas

Possible M&A opportunities

Does the group need to consider strengthening its balance sheet?

Update on the EarlyCDT lung cancer test

Why is the yearend being changed from May to Aug?

Future newsflow

Typical contract values/duration

Size of orderbook

In this interview, Adam Hill, CEO of Oncimmune #ONC - a global immunodiagnostics firm with a leading position in autoimmune profiling - explains:

How the ImmunoINSIGHTS platform is typically used. Start
Strategy of developing preferred supplier agreements with the world’s top BioPharmas. 03:35
The division's H1 performance & expected growth trajectory for the rest of the year. 06:15
Possible M&A opportunities. 12:20
Does the group need to consider strengthening its balance sheet? 13:45
Update on the EarlyCDT lung cancer test. 14:40
Why is the yearend being changed from May to Aug? 16:50
Future newsflow. 18:25
Typical contract values/duration. 19:20
Size of orderbook 20:25

In this interview, Adam Hill, CEO of Oncimmune #ONC - a global immunodiagnostics firm with a leading position in autoimmune profiling - explains:How the ImmunoINSIGHTS platform is typically used. Start Strategy of developing preferred supplier agreements with the world’s top BioPharmas. 03:35 The division's H1 performance &amp; expected growth trajectory for the rest of the year. 06:15 Possible M&amp;A opportunities. 12:20 Does the group need to consider strengthening its balance sheet? 13:45 Update on the EarlyCDT lung cancer test. 14:40 Why is the yearend being changed from May to Aug? 16:50 Future newsflow. 18:25 Typical contract values/duration. 19:20 Size of orderbook 20:25

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/421/003421/video_H28KHpW.mp4